Clinical Trial Update: Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the efficacy and safety of adding teneligliptin to insulin therapy in patients with Type 2 Diabetes Mellitus, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Teneligliptin (Teneligliptin)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2017-01-05